Oral Abstract Session:
87. Pertussis Vaccines and Challenges
Friday, October 21, 2011: 2:15 PM-4:15 PM
Room: 156ABC

Learning Objectives:


Target Audience: Academicians, other

Topical Category: I. Adult and Pediatric Vaccines

Tracks: Pediatric ID, Adult ID

Moderators:  Sarah Long, MD, St. Christopher's Hospital for Children, Drexel University College of Medicine and Kathryn Edwards, MD, FIDSA, Vanderbilt University Medical Center


2:30 PM
Increased Risk for Pertussis at 7-10 Years is Associated with Younger Age at 4-6 Year Old Booster DTaP
Irini Daskalaki, MD ; Liyuan Ma, MS ; Claire Newbern, PhD, MPH ; Kendra Viner, PhD, MPH ; Sarah Long, MD ; Caroline C. Johnson, MD

2:45 PM
DTaP Effectiveness: Results from the California Pertussis Vaccine Effectiveness Assessment
Lara K. Misegades, PhD, MS ; Kathleen Winter, MPH ; Kathleen Harriman, PhD, MPH, RN ; John Talarico, DO, MPH ; Thomas Clark, MD, MPH ; Stacey W. Martin, MS

3:00 PM
Rapid Rise of Incidence Rates of Pertussis in the Five Years Following Complete DTaP Vaccination: Is Immunity Waning Earlier than Expected?
Sara Tartof, PhD, MPH ; Melissa Lewis, MPH ; Cynthia Kenyon, MPH ; Karen White, MPH ; Elizabeth Zell, MStat ; Thomas Clark, MD, MPH ; Tami Skoff, MS

3:15 PM
Pertussis (Tdap) Vaccine Effectiveness
Roger Baxter, MD ; Joan Bartlett, MPH ; Ali Rowhani-Rahbar, MD, MPH, PhD ; Bruce Fireman, MS ; Nicola Klein, MD, PhD

3:30 PM
Protecting Newborns from Pertussis through Improving the Rate of Post-Partum Tetanus, Diptheria, and Acellular Pertussis (Tdap) Vaccination via a Pharmacist Driven Protocol
Lindsey Klish, Pharm.D. ; Michael Ruggero, Pharm.D. ; Heather Lipkind, MD ; Liz O'Mara, RN, BSN ; Sarah Arnold, Pharm.D. ; Jeffrey Topal, MD

3:45 PM
Preventing Infant Pertussis: A Decision Analysis Comparing Prenatal Vaccination to Cocooning
Andrew Terranella, MD, MPH ; Garrett Asay, PhD ; Mark Messonnier, PhD ; Thomas Clark, MD, MPH ; Jennifer Liang, DVM

CME Credits:

ACPE Credits:

ACPE Number:


S. Long, None

K. Edwards, None

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.